The authors review the progress in defining the key developmental and functional attributes of type 1 conventional dendritic cells (cDC1s) and the approaches to optimizing the potency of cDC1s for anticancer immunity.
[Trends in Immunology]
Sorry, but the selected Zotpress account can't be found.